S

Sutter Health | Center of Excellence in Diabetes and Endocrinology

Research site

(Unclaimed)

Location

3814 Auburn Blvd, suite 72,, Sacramento, California, United States of America

Site insights

Top conditions

Top treatments

Tirzepatide

Ertugliflozin

PF-04971729

somatrogon

BMF-219

MK-8835-059

Genotropin

LUM-201

MK-8835

LY3298176

Parent organization

This site is a part of Sutter Health

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 8 total trials

A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)

The goal of the study is to assess how tirzepatide impacts bodyweight and cardiovascular risk factors when used in conjunction with healthy nutrition...

Enrolling

Weight Gain

Obesity

Drug: Tirzepatide

Drug: Placebo

A Study to Evaluate Tirzepatide (LY3298176) in Pediatric and Adolescent Participants With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin or Basal Insulin or Both (SURPASS-PEDS)

The purpose of this study is to learn more about the safety and efficacy of tirzepatide compared to placebo in children or teenagers with type 2 diab...

Active, not recruiting

Type2 Diabetes

Glucose Metabolism Disorders

Drug: Placebo

Drug: Tirzepatide Dose 2

Ertugliflozin Type 2 Diabetes Mellitus (T2DM) Pediatric Study (MK-8835/PF-04971729) (MK-8835-059)

This study will evaluate the safety and efficacy of ertugliflozin (MK-8835) in pediatric participants with T2DM on metformin with/without insulin. Th...

Active, not recruiting

Type 2 Diabetes Mellitus

Biological: Insulin

Drug: Placebo to ertugliflozin 5 mg